Brief: Novabay Pharmaceuticals Reports Third Quarter 2022 Financial Results
14/11/2022 21:18
Nov 14 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS
* NOVABAY PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nBwh79PXa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing